Literature DB >> 1915507

Myopathy in Williams-Beuren syndrome.

T Voit1, H Kramer, C Thomas, W Wechsler, H Reichmann, H G Lenard.   

Abstract

Williams-Beuren syndrome (WBS) is a disorder of unknown aetiology. The classical features of the syndrome include a typical ('elfin') facies, mental retardation and heart defects. Myopathy has not so far been part of the spectrum of WBS. We studied six patients with WBS aged 3-25 years, five of whom showed clinical and morphological evidence of myopathy. The clinical manifestations of myopathy included hypotonia in infancy, walking delay, joint contractures, scoliosis, and increased exhaustion on exertion. These symptoms were present in variable expression but part of a typical postural pattern. Examination of muscle biopsies showed lipid storage in four patients and increased variability of fibre size in three. In one patient a muscle biopsy gave normal results. Biochemical investigation in four patients with morphological evidence of lipid storage in muscle revealed muscle carnitine deficiency in three. In addition, enzyme activities of fatty acid beta-oxidation were low in one of two specimens tested. It is concluded that a clinically relevant myopathy is part of the multi-system manifestation of WBS and a clinical trial of carnitine supplementation is justified.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915507     DOI: 10.1007/bf01958438

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  28 in total

1.  The Williams elfin facies syndrome. A new perspective.

Authors:  K L Jones; D W Smith
Journal:  J Pediatr       Date:  1975-05       Impact factor: 4.406

2.  ASSOCIATION BETWEEN AORTIC STENOSIS AND FACIES OF SEVERE INFANTILE HYPERCALCAEMIA.

Authors:  J A BLACK; R E CARTER
Journal:  Lancet       Date:  1963-10-12       Impact factor: 79.321

3.  An improved and simplified radioisotopic assay for the determination of free and esterified carnitine.

Authors:  J D McGarry; D W Foster
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

4.  Impaired calcium homeostasis in the infantile hypercalcemic syndrome.

Authors:  G B Forbes; M F Bryson; J Manning; G H Amirhakimi; J C Reina
Journal:  Acta Paediatr Scand       Date:  1972-05

Review 5.  Williams syndrome.

Authors:  J Burn
Journal:  J Med Genet       Date:  1986-10       Impact factor: 6.318

6.  The Williams syndrome: objective definition and diagnosis.

Authors:  M Preus
Journal:  Clin Genet       Date:  1984-05       Impact factor: 4.438

7.  Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.

Authors:  C R Roe; D S Millington; D A Maltby; T P Bohan; S G Kahler; R A Chalmers
Journal:  Pediatr Res       Date:  1985-05       Impact factor: 3.756

8.  Cognitive processing of children with Williams syndrome.

Authors:  J J Crisco; J M Dobbs; R K Mulhern
Journal:  Dev Med Child Neurol       Date:  1988-10       Impact factor: 5.449

Review 9.  Carnitine metabolism and deficiency syndromes.

Authors:  C J Rebouche; A G Engel
Journal:  Mayo Clin Proc       Date:  1983-08       Impact factor: 7.616

10.  Neurologic features of Williams and Down syndromes.

Authors:  D A Trauner; U Bellugi; C Chase
Journal:  Pediatr Neurol       Date:  1989 May-Jun       Impact factor: 3.372

View more
  3 in total

1.  Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle promoter activity.

Authors:  Enoch S E Tay; Kim L Guven; Nanthakumar Subramaniam; Patsie Polly; Laura L Issa; Peter W Gunning; Edna C Hardeman
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

2.  Anesthesiological Management of a Patient with Williams Syndrome Undergoing Spine Surgery.

Authors:  Federico Boncagni; Luca Pecora; Vasco Durazzi; Francesco Ventrella
Journal:  Case Rep Anesthesiol       Date:  2016-03-16

Review 3.  Crosstalk among Calcium ATPases: PMCA, SERCA and SPCA in Mental Diseases.

Authors:  Tomasz Boczek; Marta Sobolczyk; Joanna Mackiewicz; Malwina Lisek; Bozena Ferenc; Feng Guo; Ludmila Zylinska
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.